Colistin Utilization Evaluation in a Major Teaching Hospital in Iran

Background: Colistin is an old antibacterial agent which is used in multiple drug resistant (MDR) infections. Due to increased rate of MDR infections, the use of this agent is raised in worldwide. The aim of this study was to identify colistin utilization patterns in a teaching hospital. Methods: This retrospective cross-sectional study was performed between Augusts 2017 and December 2017 at Firoozgar hospital affiliated to Iran University of Medical Sciences, Tehran, Iran. All colistin prescriptions for adult patients during the study period were enrolled for appropriateness evaluation according to the Lexi comp acquired by Wolters Kluwer and National Health Service (NHS) guideline. Results: Among 70 patients who received colistin, pneumonia (70%) was the chief indication of colistin prescription. In 96% of cases, colistin was prescribed according to microbiological laboratory results. In 14% of patients, colistin administration was before providing microbiological laboratory evidence. Seventeen percent of the patients received loading dose of colistin. The interval between loading and maintenance doses were incorrect in all of these patients. 73% and 67% of the prescribed doses at the initiation and end of colistin therapy were appropriate. The time interval and duration colistin therapy were appropriate in 78% and 52% of patients, respectively. The mean of creatinine clearance reduced statistically significant, 81.95 ± 39.89 and 70.85 ± 38.80 in the first and end of days of colistin therapy, respectively (P: 0.004). Conclusion: These findings support the requirement for physicians’ educational programs and suitable strategies for appropriate prescriptions. J Pharm Care 2018; 6(1-2): 19-22. ► Please cite this paper as: Rezaie N, Farasatinasab M, Vaiszadeh N, Jamshidi M, Ranjbar M, Yasin Z, Ghanberi B, Pakdaman N. Colistin Utilization Evaluation in a Major Teaching Hospital in Iran. J Pharm Care 2018; 6(1-2): 19-22. * Corresponding Author: Dr Maryam Farasatinasab Address: Firoozgar Hospital, Beh Afarin St., Karim khan-e-Zand St., Tehran, Iran. Tel: +982182141201. E-mail: maryfarasati@gmail.com jpc.tums.ac.ir

[1]  Afsaneh Vazin,et al.  Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran , 2017, Advanced pharmaceutical bulletin.

[2]  I. Karimzadeh,et al.  Evaluating the resistance pattern of gram-negative bacteria during three years at the nephrology ward of a referral hospital in southwest of Iran , 2017, Journal of nephropathology.

[3]  Jason C. Gallagher,et al.  Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae , 2015, Antimicrobial Agents and Chemotherapy.

[4]  M. Motamedifar,et al.  Antibiotic Resistance Profile and Distribution of Oxacillinase Genes Among Clinical Isolates of Acinetobacter baumannii in Shiraz Teaching Hospitals, 2012 - 2013 , 2015, Jundishapur journal of microbiology.

[5]  S. Dashti-Khavidaki,et al.  Colistin: efficacy and safety in different populations , 2015, Expert review of clinical pharmacology.

[6]  C. Landersdorfer,et al.  Colistin: How should It Be Dosed for the Critically Ill? , 2015, Seminars in Respiratory and Critical Care Medicine.

[7]  M. Ferreira,et al.  Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome. , 2014, Journal of medical microbiology.

[8]  A. Rossati,et al.  Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review , 2014, Infection.

[9]  H. Fazeli,et al.  Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[10]  G. Maartens,et al.  Systematic review of the evidence for rational dosing of colistin. , 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[11]  S. Shoja,et al.  Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran , 2013, Iranian journal of microbiology.

[12]  F. Najafi,et al.  Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran , 2013, Iranian journal of microbiology.

[13]  A. Salmanian,et al.  Distribution of OXA-Type Class D β-Lactamase Genes Among Nosocomial Multi Drug Resistant Acinetobacter baumannii Isolated in Tehran Hospitals , 2013 .

[14]  M. Saidijam,et al.  High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. , 2013, Journal of research in health sciences.

[15]  F. Shahcheraghi,et al.  Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals , 2011, Iranian journal of microbiology.

[16]  M. Davarpanah,et al.  Ventilator-associated pneumonia in Iranian intensive care units. , 2011, Journal of infection in developing countries.

[17]  I. Truter.  A Review of Drug Utilization Studies and Methodologies , 2010 .

[18]  D. Paterson,et al.  Management of meningitis due to antibiotic-resistant Acinetobacter species. , 2009, The Lancet. Infectious diseases.

[19]  D. Paterson.  Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  E. Douzinas,et al.  Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. , 2008, The Journal of infection.

[21]  E. Koratzanis,et al.  Colistin susceptibility testing by Etest and disk diffusion methods. , 2008, International journal of antimicrobial agents.